spectrophotometry

DEVICE2 trials

Sponsors

Barbara Ann Karmanos Cancer Institute, Intensive Care National Audit & Research Centre

Conditions

Adenocarcinoma of the ProstateCritical IllnessHormone-resistant Prostate CancerHypoxemiaRecurrent Prostate CancerStage IV Prostate Cancer

Phase 2

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

CompletedNCT01270880

Barbara Ann Karmanos Cancer InstituteAdenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer +1

Start: 2011-01-31End: 2014-07-31Updated: 2018-09-18

Unknown Phase

Exploring Pulse OXimeter Accuracy Across SKin Tones

CompletedNCT05481515

Intensive Care National Audit & Research CentreCritical Illness, Hypoxemia

Start: 2022-06-24End: 2024-10-31Updated: 2025-03-12

Related Papers

The impact of skin tone on performance of pulse oximeters used by NHS England COVID Oximetry @home scheme: measurement and diagnostic accuracy study.

2026-01-14